A lung biopsy found that a man who died in China from the new coronavirus last month had lung damage reminiscent of two prior coronavirus-related outbreaks, SARS and MERS.
The patient died on Jan. 27 after falling ill two weeks earlier and becoming increasingly breathless. Doctors bombarded him with various medications in attempts to save his life, including anti-infection treatment alfa-2b, AIDS medicines lopinavir and ritonavir and the antibiotic moxifloxacin to prevent secondary bacterial infection. He also received a steroid to treat inflamed lungs and “serious shortness of breath” and a lack of oxygen in his blood.
He reported traveling to Wuhan, China, where the COVID-19 outbreak began, from Jan. 8-12 and experienced initial symptoms of mild chills and a dry cough on Jan. 14, the first day of the illness.